Women’s health, cardiovascular risk and hypertension: the perspective still needs to improve

References

• Wenger NK, Lloyd-Jones DM, Elkind MSV, et al. Call to action for cardiovascular disease in women: epidemiology, awareness, access, and delivery of equitable health care: a presidential advisory from the American heart association. Circulation. 2022;145:1–4.
   Web of Science ®Google Scholar
• Accounting for sex and gender makes for better science. Nature. 2020;588:196.
   PubMed Web of Science ®Google Scholar
• Arnegard ME, Whitten LA, Hunter C, et al. Sex as a biological variable: a 5-year progress report and call to action. J Womens Health. 2020;29:858–864.
   PubMed Web of Science ®Google Scholar
• Gooding HC, Brown CA, Liu J, et al. Will teens go red? Low cardiovascular disease awareness among young women. J Am Heart Assoc. 2019;8:e011195.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Sudano I, Brouwers S, et al. Sex differences in arterial hypertension. Eur Heart J. 2022;43:4777–4788.
   PubMedGoogle Scholar
• Nielsen MW, Andersen JP, Schiebinger L, et al. One and a half million medical papers reveal a link between author gender and attention to gender and sex analysis. Nat Hum Behav. 2017;1:791–796.
   PubMed Web of Science ®Google Scholar
• Regensteiner JG, Reusch JEB. Sex differences in cardiovascular consequences of hypertension, obesity, and diabetes: JACC focus seminar 4/7. J Am Coll Cardiol. 2022;79:1492–1505.
   PubMed Web of Science ®Google Scholar
• Cushman M, Shay CM, Howard VJ, et al. Ten-Year differences in women’s awareness related to coronary heart ­disease: results of the 2019 American heart association national survey: a special report from the American heart association. Circulation. 2021;143:e239–e248.
   PubMed Web of Science ®Google Scholar
• Maffei S, Meloni A, Deidda M, Igenda Study G, et al. Cardiovascular risk perception and knowledge among italian women: lessons from IGENDA protocol. J Clin Med. 2022;11(6):1695.
   PubMed Web of Science ®Google Scholar
• Mosca L, Mochari-Greenberger H, Dolor RJ, et al. Twelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010;3:120–127.
   PubMed Web of Science ®Google Scholar
• Beussink-Nelson L, Baldridge AS, Hibler E, et al. Knowledge and perception of cardiovascular disease risk in women of reproductive age. Am J Prev Cardiol. 2022;11:100364.
   PubMedGoogle Scholar
• Arora S, Stouffer GA, Kucharska-Newton AM, et al. Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019;139:1047–1056.
   PubMed Web of Science ®Google Scholar
• Brown RM, Tamazi S, Weinberg CR, et al. Racial disparities in cardiovascular risk and cardiovascular care in women. Curr Cardiol Rep. 2022;24:1197–1208.
   PubMed Web of Science ®Google Scholar
• O'Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res. 2022;130:652–672.
   PubMed Web of Science ®Google Scholar
• Davis GK, Henry A, Arnott C, et al. The long-term cardiovascular impact of hypertension in pregnancy – a missed opportunity. Austr N Z J Obstetr Gynaecol. 2021;61:474–477.
   PubMed Web of Science ®Google Scholar
• Daitch V, Turjeman A, Poran I, et al. Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis. Trials. 2022;23:1038.
   PubMedGoogle Scholar
• Group SR, Wright JT, Jr., Williamson JD, et al. A randomized trial of intensive versus standard Blood-Pressure control. N Engl J Med. 2015;373:2103–2116.
   PubMed Web of Science ®Google Scholar
• Bhattarai M, Salih M, Regmi M, et al. Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcomes in patients with type 2 diabetes and other risk factors for cardiovascular disease: a meta-analysis. JAMA Netw Open. 2022;5:e2142078.
   PubMed Web of Science ®Google Scholar
• Razuk V, Chiarito M, Cao D, et al. SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022;8:557–567.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43:474–484.
   PubMed Web of Science ®Google Scholar
• Reckelhoff JF. Mechanisms of sex and gender differences in hypertension. J Hum Hypertens. 2023; 16:1–6.
   Google Scholar
• Barris CT, Faulkner JL, Belin de Chantemèle EJ. Salt sensitivity of blood pressure in women. Hypertension. 2023;80(2):268–278.
   PubMed Web of Science ®Google Scholar
• Ji H, Niiranen TJ, Rader F, et al. Sex differences in blood pressure associations with cardiovascular outcomes. Circulation. 2021;143:761–763.
   PubMed Web of Science ®Google Scholar
• Foy CG, Lovato LC, Vitolins MZ, et al. Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the systolic blood pressure intervention trial. J Hypertens. 2018;36:904–915.
   PubMedGoogle Scholar
• Delles C, Currie G. Sex differences in hypertension and other cardiovascular diseases. J Hypertens. 2018;36:768–770.
   PubMedGoogle Scholar
• Cífková R, Strilchuk L. Sex differences in hypertension. Do we Need a Sex-Specific Guideline? Front Cardiovasc Med. 2022;9:960336.
   PubMed Web of Science ®Google Scholar
• Polaczyk M, Olszanecka A, Wojciechowska W, et al. The occurrence of drug-induced side effects in women and men with arterial hypertension and comorbidities. Kardiol Pol. 2022;80:1094–1103.
   PubMedGoogle Scholar
• Meinert F, Thomopoulos C, Kreutz R. Sex and gender in hypertension guidelines. J Hum Hypertens. 2023;10:1–8.
   Google Scholar
• Bager JE, Manhem K, Andersson T, et al. Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care. J Hum Hypertens. 2023;27(3):176–181.
   Google Scholar